Literature DB >> 14987277

Erythrocyte superoxide dismutase, catalase activities and plasma nitrite and nitrate levels in patients with Behçet disease and recurrent aphthous stomatitis.

K Gunduz1, G Ozturk, E Y Sozmen.   

Abstract

Behçet disease (BD) and recurrent aphthous stomatitis (RAS) are two distinct diseases of unknown aetiology which are both characterized by oral aphthae. The aim of this study was to determine the possible association of both diseases with antioxidant status and nitric oxide levels. Twenty-six patients (17 female, nine male) with RAS, 28 patients (17 female, 11 male) with BD and 31 (22 female, nine male) healthy control subjects were included in the study. Blood samples were studied for erythrocyte superoxide dismutase (SOD) and catalase (CAT) activities and plasma nitric oxide (NO) levels. Erythrocyte SOD activity in BD patients was significantly higher than in RAS patients and controls. Although SOD activity in RAS patients was higher than in controls, the difference was not statistically significant. No significant differences in CAT activities or NO levels were found between the three groups. In conclusion, changes in SOD activity may be important in the inflammatory reactions observed in BD and RAS, but NO does not seem to play a primary role in the aetiopathogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14987277     DOI: 10.1111/j.1365-2230.2004.01488.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  9 in total

1.  Effect of Yisui Shengxue Granule () on the oxidative damage of erythrocytes from patients with hemoglobin H disease.

Authors:  Wen-Juan Wang; Zhi-Kui Wu; Xin-Hua Zhang; Yong-Mei Liu; Su-Ping Fang; Chong Zhang; Wen-Jun Liu; Min Li; Rong-Xin Wang; Rui-Gui Luo; Ping-Ping Li
Journal:  Chin J Integr Med       Date:  2012-08-31       Impact factor: 1.978

2.  A panel of oxidative stress assays does not provide supplementary diagnostic information in Behcet's disease patients.

Authors:  Yasemin D Akcay; Ferhan G Sagin; Kenan Aksu; Gokhan Keser; Emma Taylor; Iona Knight; Paul G Winyard; Eser Y Sozmen
Journal:  J Inflamm (Lond)       Date:  2012-04-03       Impact factor: 4.981

3.  Total serum oxidant/antioxidant status and arylesterase activity in recurrent aphthous stomatitis.

Authors:  Gulsen Akoglu; Ahmet Metin; Fadime Kilinc; Suzan Demir Pektas; Semra Isikoglu; Ayse Akbas; Sertac Sener
Journal:  Ann Dermatol       Date:  2013-08-13       Impact factor: 1.444

4.  Oxidative stress and cellular immunity in patients with recurrent aphthous ulcers.

Authors:  E Avci; Z Z Akarslan; H Erten; S Coskun-Cevher
Journal:  Braz J Med Biol Res       Date:  2014-05-02       Impact factor: 2.590

5.  Assessment of serum enzymatic antioxidant levels in patients with recurrent aphthous stomatitis: a case control study.

Authors:  Ishita Gupta; Arvind Shetti; Vaishali Keluskar; Anjana Bagewadi
Journal:  Enzyme Res       Date:  2014-12-10

6.  Evaluation of antioxidant activities of ampelopsin and its protective effect in lipopolysaccharide-induced oxidative stress piglets.

Authors:  Xiang Hou; Jingfei Zhang; Hussain Ahmad; Hao Zhang; Ziwei Xu; Tian Wang
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

7.  The Serum and salivary level of malondialdehyde, vitamins A, E, and C in patient with recurrent aphthous stomatitis.

Authors:  Heidar Khademi; Faezeh Khozeimeh; Atefeh Tavangar; Sima Amini; Parichehr Ghalayani
Journal:  Adv Biomed Res       Date:  2014-12-06

8.  Serum levels of total antioxidant status, nitric oxide and nitric oxide synthase in minor recurrent aphthous stomatitis patients.

Authors:  Zichuan Zhang; Qian Zhang; Yi Xue; Guang Chen; Zhongyin Wu; Huiqing Fang
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

9.  Genetic Polymorphism of Manganese Superoxide Dismutase in Behçet's Disease.

Authors:  Efkan Uz; H Ramazan Yilmaz; Ramazan Yağci; İsmail Akyol; Tuğba Ersoy; Gülten Sungur; Ayşe Yiğit; Sunay Duman; Ömer Akyol
Journal:  Arch Rheumatol       Date:  2015-12-14       Impact factor: 1.472

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.